Mr. Edward A. Blechschmidt

• 
  www.sec.gov/Archives/edgar/data/1186623/0001140361-08-0 - [Cached Version]
  Published on: 5/15/2008    Last Visited: 5/16/2008  

  0001186623 BLECHSCHMIDT EDWARD A 202 RADNOR-CHESTER ROAD VILLANOVA PA 19085 1 0 0 0

• 
  investors.gentiva.com/releasedetail.cfm?ReleaseID=19648 - [Cached Version]
  Published on: 10/13/2008    Last Visited: 8/13/2007  

  "The closing of this transaction enables Gentiva to focus its resources and leverage its expertise in the home health care industry," said Edward A. Blechschmidt, Gentiva's president, chairman and chief executive officer.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=189398&p=irol-govB - [Cached Version]
  Published on: 10/2/2008    Last Visited: 10/2/2008  

  Ed BlechschmidtDiamond Foods - Biography> window.addEvent('domready', function() { var accordion = new Accordion('h6.atStart', 'div.atStart', { opacity: false, // Set this display number for which Side bar menu will be expanded upon landing on this particular page // About us = 0 // Stock Information = 1 // News & Events = 2 // Financial Information = 3 display: 4, onActive: function(toggler, element) { toggler.setStyle('color', '#cc9966'); }, onBackground: function(toggler, element) { toggler.setStyle('color', '#663300'); } }, $('accordion')); }); >
  ...
  Ed Blechschmidt
  
  Mr. Blechschmidt joined Diamond's Board in March 2008.Mr. Blechschmidt was Chief Executive Officer of Novelis Corp. from December 2006 until its sale to the Birla Group on May 2007.He was Chairman, Chief Executive Officer and President of Gentiva Health Services, Inc., a leading provider of specialty pharmaceutical and home health care services, from March 2000 to June 2002.From March 1999 to March 2000, Mr. Blechschmidt served as Chief Executive Officer and a director of Olsten Corporation, the conglomerate from which Gentiva Health Services was slit off and taken public.He served a President of Olsten from October 1998 to March 1999.He also served as President and Chief Executive Officer of Siemens Nixdorf America and Siemens Pyramid Technologies from July 1996 to October 1998.Prior to Siemens, he spent more than 20 years with Unisys Corporation, including serving as its Chief Financial Officer.Mr Blechschmidt serves as a director of Healthsouth Corp., which he joined in 2004 as part of the company's transition plan to strengthen its corporate governance, Lionbridge Technologies, Inc., and Columbia Laboratories, Inc.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=187479&p=irol-news - [Cached Version]
  Published on: 10/13/2008    Last Visited: 11/23/2007  

  ATLANTA, June 30 /PRNewswire-FirstCall/ -- Novelis Inc. (NYSE: NVL) (TSX: NVL) today announced that it has appointed a new independent director, Edward A. Blechschmidt, to its Board of Directors.Mr. Blechschmidt retired in 2002 as Chairman and Chief Executive Officer of Gentiva Health Services, Inc., a leading provider of specialty pharmaceutical and home health care services that was spun off from Olsten Corporation and taken public.He remained a director until May 2005.
  
  This appointment takes effect immediately and continues until Novelis' 2006 annual meeting, when Mr. Blechschmidt will be nominated for election to serve in the coming year.The annual meeting has been delayed and will take place by the end of 2006.
  
  William T. Monahan, Chairman of the Board, said, "We are very pleased to welcome Ed Blechschmidt to Novelis' Board of Directors.
  ...
  Mr. Blechschmidt fills the second of two vacancies that resulted from the previously announced increase in the maximum size of Novelis' Board from 12 to 14 members.
  ...
  Before joining Gentiva in 2000, Mr. Blechschmidt, 53, served as Chief Executive Officer and a director of Olsten Corporation, the conglomerate from which Gentiva Health Services was spun off.He served as President of Olsten from October 1998 to March 1999.He also served as President and Chief Executive Officer of Siemens Nixdorf Americas and Siemens Pyramid Technologies from July 1996 to October 1998.Prior to that, he spent more than 20 years with Unisys Corporation, where he held positions of increasing responsibility in finance, administration and operations, including Chief Financial Officer.
  
  Mr. Blechschmidt serves as a director of HealthSouth Corp., having joined the Board in 2004, Lionbridge Technologies, Inc., Option Care, Inc., and Columbia Laboratories, Inc.He serves as Chair of the Audit Committees of the Boards of HealthSouth and Lionbridge Technologies.
  
  Mr. Blechschmidt earned his bachelor's degree in business from Arizona State University.
  ...
  Examples of forward-looking statements in this news release include, among other matters, Novelis' ability to execute on its business strategy, hold an annual meeting by the end of 2006, and that Mr. Blechschmidt will be nominated for election at such meeting.Novelis cautions that, by their nature, forward-looking statements involve risk and uncertainty, that the annual meeting could be further delayed in the event Novelis has not issued its annual report on Form 10-K for the fiscal year ended 2005 by the end of 2006, and that Mr. Blechschmidt has not yet been nominated for election at the 2006 annual meeting.

• 
  www.sec.gov/Archives/edgar/data/1218321/0000902664-08-0 - [Cached Version]
  Published on: 3/28/2008    Last Visited: 8/9/2008  

  We recommend that stockholders elect Edward A. Blechschmidt, Joachim V. Hirsch and Timothy D. Leuliette as directors of the Company at the 2008 Annual Meeting.
  ...
  Edward A. Blechschmidt Edward A. Blechschmidt was named Chief Executive Officer of Novelis, Inc. in
  ...
  Mr. Blechschmidt is currently retired from active management positions.
  
  Mr. Blechschmidt was Chairman, Chief Executive Officer and President of Gentiva Health Services (NASDAQ: GTIV), the nation's leading provider of specialty pharmaceutical and home health care services, from March, 2000 until June, 2002.A Fortune 1000 company, Gentiva Health Services reported $1.4 billionin 2001 in 2001 revenues.Mr. Blechschmidt retired as an officer from Gentiva after the completion of a sale of their pharmaceutical business to Accredo Health, Inc. in June, 2002 but continued on the board until May, 2005.
  
  Mr. Blechschmidt holds an undergraduate degree in business from Arizona State University.He is a member of the board of directors of Healthsouth Corp. (Chair: Audit Comm.), Columbia Laboratories, Inc. (Vice Chairman, Comp.Comm., Scientific Comm., Nominating Comm.), and Lionbridge Technologies, Inc. (Chair: Audit Comm.).He has held board directorships with Novelis, Inc. (CEO), Option Care, Inc., Olsten Corp. (CEO), Gentiva Health Services, Inc. (Chairman & CEO), Neoforma, Inc. (Chair: Audit Comm.), Garden Fresh Restaurant Corp. (Chair: Audit Comm.), R2 Technology, Inc. (Chair: Audit Comm.), EA Industries (Chair: Audit Comm.), and the American Association of Homecare.He is also involved with various private companies and charitable organizations.
  ...
  Edward A Blechschmidt
  ...
  Blechschmidt, Hirsch and Leuliette have each entered into a Nominee Agreement pursuant to which the Investment Manager has agreed to pay the costs of soliciting proxies in connection with the 2008 Annual Meeting, and to defend and indemnify each of the Nominees with respect to any losses that may be incurred by them in the event they become a party to litigation based on their nomination as candidates for election to the board of directors of the Company and the solicitation of proxies in support of their election.

• 
  www.tx001.com/mold/doc031304--Aluminum-Permanent-Mold-C - [Cached Version]
  Published on: 3/13/2004    Last Visited: 11/26/2007  

  Novelis Director Edward A. Blechschmidt Appointed Acting CEO bi13042215 Novelis the global leader aluminum rolled products and aluminum can recycling.

• 
  www.cbrxir.com/2004_Press_Releases/110404.html - [Cached Version]
  Published on: 11/4/2004    Last Visited: 8/9/2008  

  Strengthened Board of Directors with election of Edward Blechschmidt and Stephen Kasnet.

• 
  www.sec.gov/Archives/edgar/data/1058299/0001193125-08-0 - [Cached Version]
  Published on: 4/7/2008    Last Visited: 8/10/2008  

  Edward A. Blechschmidt
  ...
  Edward A. Blechschmidt was elected a director of Lionbridge on February 4, 2003.Mr. Blechschmidt served as acting Chief Executive Officer of Novelis, Inc., a producer of rolled aluminum products, from January through May 2007.He previously served as Chairman, Chief Executive Officer and President of Gentiva Health Services, a provider of specialty pharmaceutical and home health services, from March 2000 until July 2002.He served as President and Chief Operating Officer of the Olsten Corporation from October 1998 through March 2000, and was its Chief Executive Officer from February 1999 through March 2000.From 1996 to 1998, Mr. Blechschmidt served as President and Chief Executive Officer of Siemens Nixdorf Americas and Siemens' Pyramid Technology, as well as Executive Vice President and as a director of its parent company, Siemens Nixdorf Informationssysteme AG.Prior to joining Siemens, Mr. Blechschmidt served for more than 20 years with Unisys Corporation, a leading global provider of information technology and consulting services, including in the position of Chief Financial Officer.Mr. Blechschmidt is a director of Diamond Foods, Inc., HealthSouth Corporation and Columbia Laboratories, Inc.
  ...
  Blechschmidt, de Chazal, and Goodman—are independent within the meaning of the Lionbridge Independent Director Standards, the NASD Standards, and the SEC's director independence standards for audit committee members (the "SEC Standards").
  ...
  The Board has determined in accordance with the rules of the Securities and Exchange Commission that Mr. Blechschmidt, who serves as Chairman of the Audit Committee, is an audit committee financial expert.

• 
  phx.corporate-ir.net/phoenix.zhtml?c=189398&p=NewsArtic - [Cached Version]
  Published on: 3/28/2008    Last Visited: 6/23/2008  

  STOCKTON, Calif.--(BUSINESS WIRE)--March 28, 2008--Diamond Foods, Inc. (NASDAQ:DMND), announced today that its Board of Directors added Edward A. Blechschmidt as a member effective March 25, 2008.In addition, Mr. Blechschmidt will serve as Chairman of the Audit Committee.
  
  Mr. Blechschmidt served as Chief Executive Officer of Novelis, Inc., the global leader of aluminum rolled products and aluminum can recycling, from December 2006 until its sale to the Birla Group in May 2007.Previously, he was Chairman, Chief Executive Office and President of Gentiva Health Services, a leading provider of specialty pharmaceutical and home health care services from 2000 through 2002.Gentiva was launched as a new public company in March, 2000 as a split-off from Olsten Corporation, where Mr. Blechschmidt served as CEO and Chief Operating Officer during 1998 and 1999.
  
  From 1996 to 1998, Mr. Blechschmidt served as President and Chief Executive Officer of Siemens Nixdorf Americas and Siemens Pyramid Technology, as well as Executive Vice President and Board member of parent company Siemens Nixdorf Informationsysteme AG.Prior to joining Siemens, Mr. Blechschmidt served for more than 20 years with Unisys Corporation, a leading global provider of information technology and consulting services, including serving as its Chief Financial Officer, Chair of its Worldwide Corporate Quality Council and as a member of the Ethics Committee.
  
  Mr. Blechschmidt is a graduate of Arizona State University and serves on the boards of Healthsouth Corp., which he joined in 2004 as part of the company's transition plan to strengthen its corporate governance, Columbia Laboratories, Inc. and Lionbridge Technologies.
  
  "We are very pleased to welcome Ed Blechschmidt to the Diamond Foods Board," said Chairman John J. Gilbert.
  ...
  "Ed is a very talented executive who brings to Diamond strong leadership and financial skills in a wide variety of industries, including technology, health care and professional services.

• 
  www.sec.gov/Archives/edgar/data/1096219/0001193125-04-0 - [Cached Version]
  Published on: 4/27/2004    Last Visited: 7/28/2004  

  Edward A. Blechschmidt(6)
  ...
  Includes 20,555 shares of common stock subject to options held by Mr. Blechschmidt that are exercisable within 60 days of April 15, 2004.

Page:  1 2 3 4 5